T_NN
cell_NN
response_NN
to_TO
Epstein-Barr_JJ
virus_NN
transactivators_NNS
in_IN
chronic_JJ
rheumatoid_JJ
arthritis_NN
._.

Rheumatoid_JJ
arthritis_NN
is_VBZ
a_DT
multistep_JJ
disorder_NN
associated_VBN
with_IN
autoimmune_JJ
features_NNS
of_IN
yet_RB
unknown_JJ
etiology_NN
._.

Implication_NN
of_IN
viruses_NNS
such_JJ
as_IN
Epstein-Barr_JJ
virus_NN
-LRB-_-LRB-
EBV_NN
-RRB-_-RRB-
in_IN
rheumatoid_JJ
arthritis_NN
pathogenesis_NN
has_VBZ
been_VBN
suspected_VBN
on_IN
the_DT
basis_NN
of_IN
several_JJ
indirect_JJ
observations_NNS
,_,
but_CC
thus_RB
far_RB
,_,
a_DT
direct_JJ
link_NN
between_IN
EBV_NN
and_CC
rheumatoid_JJ
arthritis_NN
has_VBZ
not_RB
been_VBN
provided_VBN
._.

Here_RB
we_PRP
show_VBP
that_IN
a_DT
large_JJ
fraction_NN
of_IN
T_NN
cells_NNS
infiltrating_VBG
affected_VBN
joints_NNS
from_IN
a_DT
patient_NN
with_IN
chronic_JJ
rheumatoid_JJ
arthritis_NN
recognizes_VBZ
two_CD
EBV_NN
transactivators_NNS
-LRB-_-LRB-
BZLF1_NN
and_CC
BMLF1_NN
-RRB-_-RRB-
in_IN
a_DT
major_JJ
histocompatibility_NN
complex-restricted_NN
fashion_NN
._.

Responses_NNS
to_TO
these_DT
EBV_NN
antigens_NNS
by_IN
synovial_JJ
lymphocytes_NNS
from_IN
several_JJ
other_JJ
chronic_JJ
rheumatoid_JJ
arthritis_NN
patients_NNS
were_VBD
readily_RB
detectable_JJ
._.

Thus_RB
these_DT
results_NNS
suggest_VBP
a_DT
direct_JJ
contribution_NN
of_IN
EBV_NN
to_TO
chronic_JJ
rheumatoid_JJ
arthritis_NN
pathogenesis_NN
._.

They_PRP
also_RB
demonstrate_VBP
for_IN
the_DT
first_JJ
time_NN
the_DT
occurrence_NN
of_IN
T_NN
cell_NN
responses_NNS
against_IN
EBV_NN
transactivating_VBG
factors_NNS
,_,
which_WDT
might_MD
be_VB
central_JJ
in_IN
the_DT
control_NN
of_IN
virus_NN
reactivation_NN
._.

